EVP, Head of Research & Dev · ACADIA PHARMACEUTICALS INC · Common Stock
Side
M
Value
—
Shares
6,715
Price
—
Executed
Mar 24, 2026
Disclosed
Mar 26, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 24 executedMar 26, 2026 disclosed
ACAD · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Thompson Elizabeth H.Z. filed this Form 4 reporting a option exercise of ACAD on Mar 24, 2026. It became public on Mar 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP, Head of Research & Dev
Thompson Elizabeth H.Z.cik:0001861477
Issuer
ACADIA PHARMACEUTICALS INCcik:0001070494
Revision history · 0
No field has changed since this record was first ingested.
